Delivery Order SPE2DB20D3303-SPE2DB24FY2X2
Award Date
11/9/23
Potential Completion Date
11/13/23
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,426.68 firm fixed-price delivery order (SPE2DX15D3018|SPE2DX24F0AAS) is for the supply of the drug LYBALVI 10-10 MG TABLET UU 30S. The contract has a completion date of June 21, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,467.26, is for the delivery of LYBALVI 20-10 MG TABLET UU 30S, a pharmaceutical product. The contract is a firm-fixed-price delivery order with a completion date of November 28, 2023. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,638.41 firm fixed-price delivery order is for pharmaceutical products, including the drug Lybalvi 5-10 mg tablet, to support military healthcare programs. The contract has an ultimate completion date of July 24, 2024. This is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,829.33 firm fixed-price delivery order is for the supply of LYBALVI 10-10 MG TABLET UU 30S, a pharmaceutical product, with a completion date of May 28, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,658.22, is for the delivery of LYBALVI 20-10 MG TABLET UU 30S, a medical supply product. The contract has a period of performance through May 8, 2024 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,137.49 fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes...
The U.S. government's Defense Logistics Agency (DLA) awarded a $1,346.66 firm-fixed price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which does not have a set-aside designation, covers the supply of a variety of pharmaceutical products, medical supplies, and equipment to support military healthcare programs. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $97,175.21, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that falls under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA Troop Support Medical, which runs through November 2026. This IDC enables efficient government procurement of essential pharmaceutical and medical supplies, including...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $91,642.40, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,827.51, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, which is valued at $999,999,999 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...